Skip to main content
logo
aTyr Pharma, Inc. (ATYR)
NASDAQ: ATYR · Real-Time Price · USD
0.2880
-0.0061 (-2.07%)
Oct 2, 2026, 12:41 PM EDT - Market open

aTyr Pharma Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
0.190.190.240.3510.39-
Revenue Growth
--19.15%-33.43%-96.60%--
Gross Profit
-46.9-60.03-54.14-41.94-32.42-23.26
Operating Income
-63.86-77.63-67.91-54.92-46.4-34.02
Net Income
-60.81-74.12-64.02-50.39-45.34-33.77
Earnings Per Share
-0.62-0.80-0.86-0.94-1.60-1.77
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
57.4278.6972.1398.1766.15107.91
Total Debt
11.312.0313.2815.111.531.38
Net Cash (Debt)
46.1266.6558.8483.0754.61106.53
Net Cash Growth
-31.85%13.28%-29.17%52.11%-48.74%261.74%
Net Cash Per Share
0.470.720.791.551.925.58

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-54.54-61.99-69.12-33.22-41.89-33.08
Capital Expenditures
-0.28-0.08-0.07-4.22-1.64-0.19
Free Cash Flow
-54.82-62.06-69.18-37.44-43.53-33.27
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
------
Operating Margin
-33609.47%-40856.32%-28899.57%-15557.79%-446.79%-
Pretax Margin
-32006.32%-39012.11%-27243.40%-14276.77%-436.58%-
Profit Margin
-32003.68%-39009.47%-27243.83%-14274.50%-436.53%-
FCF Margin
-28852.10%-32664.74%-29440.00%-10605.10%-419.09%-

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
151.83403.861293.07233.916.12-